Netherton Syndrome: A Case-Based Review of Diagnosis, Management, and Emerging Treatments
May 2025
in “
PubMed
”
Studysummary This case study reports that early genetic testing and targeted therapies, such as secukinumab, can significantly improve skin barrier function in patients with Netherton syndrome, despite persistent symptoms.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
Read the full study on hrcak.srce.hr →